Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | SUNIL PHARMACYLikely | 1 | ₹16,920 |
| 2 | Schedule 2 | Not yet disclosed by govt.Likely | 28 | - |
| 3 | Schedule 3 | VIKASH PHARMACEUTICALSLikely | 1 | ₹1.5 L |
| 4 | Schedule 4 | MEDICARESLikely | 2 | ₹1,890 |
| 5 | Schedule 5 | MEDI CHEMLikely | 3 | ₹1,776 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
23 Sept 2025, 11:00 amClosed
Syrup OXCARBAZEPINE 300 MG slace 5 gm slace ml ORAL SUSPENSION
bottle of 30ml
Amlodipine 10 mg Tab
Inj Disodium Edetate 37 point 5 mg
Pralidoxime 500mg slace 20ml
Inj
Tab Ethamsylate 500 mg
Tab Nebivolol 5mg
Digoxin 0 point 25 mg Tab
Digoxin 0 point 5 mg
2 ml Inj
Inj Tenecteplase 20 mg PFS
Labetalol HCl 5mg slace ml 4ml Inj
Prazosin 5 mg sustained release slace slow release Tab
Frusemide 40 mg Tab
Flovoxate 200mg Tab
8098553
GEM/2025/B/6460975
Two Packet Bid
Syrup OXCARBAZEPINE 300 MG slace 5 gm slace ml ORAL
30 days
West Bengal; Kolkata
Item wise evaluation
BOQ
7 documents required · 7 mandatory
2 yrs
₹5 L
₹5 L
20%
Exempted
23 Sept 2025
2 Sept 2025
23 Sept 2025
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Syrup OXCARBAZEPINE 300 MG slace 5 gm slace ml ORAL SUSPENSION, bottle of 30ml | Syrup OXCARBAZEPINE 300 MG/5 gm/ml ORAL SUSPENSION, bottle of 30ml | 90 | NOS | Consignee2DGLP | 30 |
| 2 | Amlodipine 10 mg Tab | Amlodipine 10 mg Tab | 1,66,875 | No | Consignee2DGLP | 30 |
| 3 | Inj Disodium Edetate 37 point 5 mg | Inj Disodium Edetate 37.5 mg | 300 | Nos, PFS | Consignee2DGLP | 30 |
| 4 | Pralidoxime 500mg slace 20ml, Inj | Pralidoxime 500mg/20ml, Inj | 60 | AMP slaceVIAL | Consignee2DGLP | 30 |
| 5 | Tab Ethamsylate 500 mg | Tab Ethamsylate 500 mg | 1,200 | NOS | Consignee2DGLP | 30 |
| 6 | Tab Nebivolol 5mg | Tab Nebivolol 5mg | 6,720 | No | Consignee2DGLP | 30 |
| 7 | Digoxin 0 point 25 mg Tab | Digoxin 0.25 mg Tab | 4,592 | No | Consignee2DGLP | 30 |
| 8 | Digoxin 0 point 5 mg, 2 ml Inj | Digoxin 0.5 mg, 2 ml Inj | 308 | AMP slaceVIAL | Consignee2DGLP | 30 |
| 9 | Inj Tenecteplase 20 mg PFS | Inj Tenecteplase 20 mg PFS. | 25 | Vial | Consignee2DGLP | 30 |
| 10 | Labetalol HCl 5mg slace ml 4ml Inj | Labetalol HCl 5mg/ml 4ml Inj | 1,788 | Amp | Consignee2DGLP | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8098553.pdf
GEM_BID
origin177_2025-07-16-19-29-56_91279ac1f6ab4ea2125aee92c8f8c0c6.pdf
BOQ
boq_item_sample_file_177_2025-07-16-19-29-56_bc04247d2a5ef73bd8bbfba2310d4863.csv
BOQ
Origin177_1ff02643-c4b7-4178-b6021752674761358_buyer11chec.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .